Accretion Nutraveda SME IPO Details, Financials, Valuation & Peers
Explore Accretion Nutraveda SME IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Overview
Accretion Nutraveda is a manufacturer specializing in Ayurvedic and nutraceutical formulations. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering a diverse range of dosage forms including tablets, capsules, syrups, powders, oils, and topical products.
Key highlights of Accretion Nutraveda include:
- Industry Focus: Blends traditional Ayurvedic knowledge with contemporary nutraceutical research to develop products targeting key wellness areas.
- Product Development: Formulations cover areas such as liver health, women’s care, bone and joint support, brain health, and respiratory well-being.
- Global Reach: Serves both Indian and overseas clients, with an international footprint in Sri Lanka, Singapore, and the United States.
- Manufacturing Excellence: Operates a certified manufacturing unit in Gujarat equipped with advanced infrastructure and holding numerous quality certifications (GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, Halal, and FSSAI licensed).
- Revenue Streams: Primarily driven by Domestic Sales and Merchant Exports (Loan License Model) and Direct Exports.
Objects of the Issue
- Purchase of Machineries for Automation in existing Manufacturing unit
- Purchase of Machineries for New Manufacturing Setup
- Funding working capital requirements of our company
- General corporate purposes
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 28 Jan - 30 Jan 2026 |
| IPO Price Band | ₹122 - ₹129 per share |
| Fresh Issue | ₹23.53 crore |
| Offer For Sale | NIL |
| Total IPO Size | ₹23.53 crore |
| Face Value | ₹10 |
| Listing On | BSE SME |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 28 Jan 2026 |
| IPO Closing Date | 30 Jan 2026 |
| Basis Of Allotment | 02 Feb 2026 |
| Refunds | 03 Feb 2026 |
| Demat Transfer | 03 Feb 2026 |
| IPO Listing Date | 04 Feb 2026 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 | 30 Sep 2025 |
|---|---|---|---|---|
| Assets | 4.06 | 4.64 | 10.86 | 16.35 |
| Total Income | 3.07 | 5.20 | 16.06 | 14.07 |
| Profit After Tax | 0.28 | 0.82 | 2.61 | 2.33 |
| EBITDA | 0.59 | 1.21 | 3.65 | 3.29 |
| NET Worth | 0.26 | 1.08 | 5.35 | 8.26 |
| Reserves and Surplus | -0.10 | 0.72 | 4.86 | 2.95 |
| Total Borrowing | 1.97 | 2.17 | 3.86 | 4.43 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|
| Accretion Nutraveda | 27.27 | 4.73 | 56.5 | 16.74 |
| Walpar Nutritions | 3.3 | 1.06 | 6.24 | 17.05 |
| Influx Healthtech | 46.99 | 4.81 | 11.1 | 38.98 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
IPO Reservation
| Investor Type | Shares Offered |
|---|---|
| Qualified Institutional Buyer (QIB) | 9,08,000 (47.29%) |
| Non-Institutional Investor (NII/HNI) | 2,76,000 (14.37%) |
| Retail Individual Investor (RII) | 6,40,000 (33.33%) |
Subscription Data from NSE and BSE
As the issue has not yet opened, subscription data is unavailable. However, you can view subscriptions for other ongoing issues here.
IPO Registrar
KFin Technologies Limited
Phone: +91 40 6716 2222/ 18003094001
Email: einward.ris@kfintech.com
Website: www.kfintech.com
Lead Managers
- Sobhagya Capital Options Pvt.Ltd.
Company Address
Accretion Nutraveda Ltd.
27 Xcelon Industrial Park-1
Vasna-Chacharwadi,
TaSanand,
Ahmedabad, -382213
Website: http://www.accretionnutraveda.com/
Phone: +91- 9904366177
Email: compliance@accretionnutraveda.com
FAQs
- What is the issue size of the Accretion Nutraveda SME IPO?The Accretion Nutraveda SME IPO has an issue size of ₹23.53 crore. This includes a fresh issue of ₹23.53 crore and an offer for sale (OFS) of NIL.
- What is the price band of the Accretion Nutraveda IPO?The price band for the Accretion Nutraveda IPO is ₹122 - ₹129 per share.
- What are the bidding dates for the Accretion Nutraveda IPO?The Accretion Nutraveda IPO will open for bidding on 28 Jan 2026 and close on 30 Jan 2026.
- What is the allotment date for the Accretion Nutraveda IPO?The allotment date for the Accretion Nutraveda IPO is 02 Feb 2026.
- What is the minimum lot size and investment required for the Accretion Nutraveda IPO?The minimum lot size for the Accretion Nutraveda IPO is 1000 shares and the minimum investment required is ₹1,29,000.
- What is the listing date for the Accretion Nutraveda IPO?The listing date for the Accretion Nutraveda IPO is 04 Feb 2026.
- What is the Accretion Nutraveda IPO grey market premium?The grey market premium (GMP) for the Accretion Nutraveda IPO is currently at ₹0, with an expected listing gain of approximately %. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.